MS patients reported improved walking after taking extended release drug Ampyra (Nasdaq: ACOR). “People with MS often experience a progressive decline in their walking ability that can begin early in their disease course. However, in many cases patients and their healthcare providers do not discuss walking impairment until it is so severe that it...




Recent Comments